A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers

Archive ouverte

Glodzik, Dominik | Morganella, Sandro | Davies, Helen | Simpson, Peter T | Li, Yilong | Zou, Xueqing | Diez-Perez, Javier | Staaf, Johan | Alexandrov, Ludmil B | Smid, Marcel | Brinkman, Arie B | Rye, Inga Hansine | Russnes, Hege | Raine, Keiran | Purdie, Colin A | Lakhani, Sunil R | Thompson, Alastair M | Birney, Ewan | Stunnenberg, Hendrik G | van de Vijver, Marc J | Martens, John W M | Børresen-Dale, Anne-Lise | Richardson, Andrea L | Kong, Gu | Viari, Alain | Easton, Douglas | Evan, Gerard | Campbell, Peter J | Stratton, Michael R | Nik-Zainal, Serena

Edité par CCSD ; Nature Publishing Group -

International audience. Somatic rearrangements contribute to the mutagenized landscape of cancer genomes. Here, we systematically interrogated rearrangements in 560 breast cancers by using a piecewise constant fitting approach. We identified 33 hotspots of large (>100 kb) tandem duplications, a mutational signature associated with homologous-recombination-repair deficiency. Notably, these tandem-duplication hotspots were enriched in breast cancer germline susceptibility loci (odds ratio (OR) = 4.28) and breast-specific 'super-enhancer' regulatory elements (OR = 3.54). These hotspots may be sites of selective susceptibility to double-strand-break damage due to high transcriptional activity or, through incrementally increasing copy number, may be sites of secondary selective pressure. The transcriptomic consequences ranged from strong individual oncogene effects to weak but quantifiable multigene expression effects. We thus present a somatic-rearrangement mutational process affecting coding sequences and noncoding regulatory elements and contributing a continuum of driver consequences, from modest to strong effects, thereby supporting a polygenic model of cancer development.

Suggestions

Du même auteur

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

Archive ouverte | Davies, Helen | CCSD

International audience. Approximately 1–5% of breast cancers are attributed to inherited mutations in BRCA1 or BRCA2 and are selectively sensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. In other cancer ty...

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Archive ouverte | Nik-Zainal, Serena | CCSD

International audience. We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations...

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Archive ouverte | Davies, Helen | CCSD

International audience. Mismatch repair (MMR)–deficient cancers have been discovered to be highly responsive to immune therapies such as PD-1 checkpoint blockade, making their definition in patients, wherethey may b...

Chargement des enrichissements...